J. B. Vermorken

机构：Antwerp University Hospital

发表论文 142 篇 · 总被引 4539 次 · h-index 32

代表论文

Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck (2010 · Annals of Oncology · 被引 131)
Cetuximab monotherapy is active in patients (pts) with platinum-refractory recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN): Results of a phase II study (2004 · Journal of Clinical Oncology · 被引 108)
Relationship of efficacy with KRAS status (wild type versus mutant) in patients with irinotecan-refractory metastatic colorectal cancer (mCRC), treated with irinotecan (q2w) and escalating doses of cetuximab (q1w): The EVEREST experience (preliminary data) (2008 · Journal of Clinical Oncology · 被引 92)
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study (2004 · Annals of Oncology · 被引 86)
Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic–pharmacodynamic study (2007 · British Journal of Clinical Pharmacology · 被引 57)
Multicentre EORTC study 16997: Feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers (2005 · European Journal of Cancer · 被引 51)